Second Opinion in Oncology
A structured second-opinion consultation reviews your diagnosis, staging, pathology, and proposed treatment plan against current NCCN and ESMO guidelines — and ends with a written summary you can share with your treating oncologist. Available with Dr. Madhav Danthala at Omega Hospitals, Gachibowli, Hyderabad.
When a second opinion makes sense
Not every cancer requires a second opinion. The cases where it most consistently changes — or thoughtfully confirms — the recommendation:
Stage III or IV cancers where the treatment plan is multi-modal, or any diagnosis where the path involves more than one decision (surgery vs neoadjuvant chemo, watch-and-wait vs immediate treatment).
Low-risk prostate cancer (active surveillance vs treatment), early-stage breast cancer (surgery first vs neoadjuvant chemo), locally advanced rectal cancer (TNT vs traditional chemoradiation), low-grade ovarian, low-risk thyroid.
Anything where local incidence is low and a higher-volume centre might know nuances the local team doesn't. Sarcomas, neuroendocrine tumours, rare lymphomas, paediatric cancers in adults.
BRCA1/2, Lynch syndrome, Li-Fraumeni — hereditary cancer syndromes add complexity that benefits from a hereditary-cancer-aware second look. Family history matters more than most people realise.
If you've been given a diagnosis and a plan in the same visit without a written summary of options, that's a reasonable trigger to ask for a structured review.
The pace of new oncology drug approvals over the last five years has been so rapid that 'nothing more to do' deserves a fresh look — particularly for advanced disease with biomarker testing that may not have been done.
How the consultation works
A second opinion is not a fifteen-minute scan-and-confirm. It is a structured review with a defined deliverable.
-
Records review (before your visit)
After you upload or send your records (form below), the team reviews the original pathology, scans, molecular testing, and the proposed plan. Any obvious gaps — missing IHC markers, untested actionable mutations, unclear staging — are flagged before the consultation so we can use the visit time productively.
-
Diagnosis and staging review
A pathology re-read is requested when the diagnosis has unusual features or low confidence. Imaging is reviewed for accurate staging. For advanced cancers, the molecular profile is checked against current standards — many advanced cancers should now be tested for actionable mutations that older protocols may have missed.
-
Treatment-plan review
The proposed plan is mapped against current NCCN and ESMO guidelines. If alternative defensible plans exist for your case, they are walked through with you — what each path involves, the trade-offs, what each option does and doesn't change about your prognosis, and how the decision relates to your own values and circumstances.
-
Written summary
Every consultation ends with a written summary — diagnosis, staging confirmed or revised, the treatment options considered, the recommendation, and any flagged tests or referrals. You can share this with your treating oncologist. Most patients find this is the document that turns a recommendation into a decision they can act on.
What to bring
Bringing the right records on the first visit saves a follow-up appointment and lets the consultation focus on the decision, not the paperwork.
-
1
Original pathology report From the biopsy or surgical specimen. If your pathology blocks are at a different lab, bring the lab name — we can request a re-read.
-
2
Imaging studies CT, MRI, PET-CT, mammography, ultrasound — bring the CD or DICOM files plus the radiologist's report. Reports alone are not enough; the images matter for the review.
-
3
Molecular and IHC results ER/PR/HER2 for breast; EGFR/ALK/ROS1/KRAS/PD-L1 for lung; MSI/KRAS/BRAF/HER2 for colorectal; BRCA/HRD for ovarian; HER2/MSI/PD-L1/CLDN18.2 for stomach. Anything tested so far. Plain-English guide to your pathology report.
-
4
Blood work and tumour markers Complete blood count, comprehensive metabolic panel, LDH, and tumour markers relevant to your cancer (CA-125, CA 19-9, CEA, PSA, AFP, β-HCG, etc.).
-
5
Proposed treatment plan in writing If your first oncologist has provided one. If not, write down what you've been told verbally — what regimen, what duration, what comes after.
-
6
A short timeline of the illness Half a page — when symptoms started, what tests were done, when the diagnosis was made, what treatment has happened so far. This saves the first ten minutes of every consultation.
-
7
Medications and allergies Current medications, doses, and any drug allergies. Particularly important for chemotherapy planning.
Request a second opinion
Upload your reports and request a structured review. The team will respond within one to two working days to confirm the consultation.
Prefer to book directly? Use the consultation cards below, or call +91 9346524080.
Frequently Asked Questions
Will my first oncologist be offended if I ask for a second opinion?
No. Second opinions are routine in oncology. Almost every oncology team is set up to release records, scans, and pathology to a different centre. Telling your first oncologist openly is the most efficient path. Records typically transfer within a few days. The doctors who would be offended are not the doctors anyone should be relying on for a cancer decision.
How often does a second opinion change diagnosis or treatment?
Published data on second opinions in oncology consistently show that approximately 20 to 30 per cent of cases see a meaningful change in diagnosis, staging, or treatment plan after a second opinion. The other 70 to 80 per cent of cases — where the second opinion confirms the first — are not wasted appointments. They convert a recommendation into a decision the patient can walk into with both feet.
Can I do a second opinion remotely?
Yes. Records, scans, and pathology can be shared digitally for a remote review. The form on this page allows uploading reports for a structured review. For complex cases, an in-person consultation at Omega Hospitals, Gachibowli, is preferred. Either format ends with a written summary you can share with your treating oncologist.
What if I've already started treatment? Is it too late?
Not at all. Mid-treatment second opinions are common — particularly when response is slower than expected, side effects are challenging, or new test results have come in. Early-treatment second opinions can adjust the rest of the plan; late-treatment second opinions can identify second-line and clinical-trial options.
How long does the consultation take?
A second-opinion consultation is typically scheduled for 45 to 60 minutes — longer than a standard outpatient visit because the records-review and the options-discussion both need protected time. The written summary follows within one to three working days.
Where is the consultation held?
In-person at Omega Hospitals, Gachibowli, Hyderabad (Mon-Sat, 10 AM to 4 PM) or Peoples Polyclinic, Manikonda (Mon-Sat, 5 PM to 7 PM). Remote consultations available via the form on this page or by calling +91 9346524080.
About Dr. Madhav Danthala
Dr. Madhav Danthala is a medical oncologist and hemato-oncologist practising at Omega Hospitals, Gachibowli, Hyderabad. He sees second-opinion consultations regularly across breast, lung, gastrointestinal, gynaecologic, and haematologic cancers. Every second-opinion consult ends with a clearly-written treatment summary you can share with your treating oncologist.
From our blog
- The Two-Oncologist Rule: When (and Why) to Get a Second Opinion Long-form essay on why oncology has more "right answers" than most fields, and how to ask for a second opinion without burning the bridge.
- Reading Your Pathology Report: A Plain-English Guide Pathology re-read is often where second opinions begin. Here's how to read the document yourself.
- Active Surveillance for Prostate Cancer Low-risk prostate is the textbook case for a second opinion — when "watch and wait" is genuinely defensible.
Book a second-opinion consultation
If you'd rather not use the form, book directly: